Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-10

Clinical Trial Update: A Comparison of the Effectiveness and Safety of ULTRACET® (Tramadol Hydrochloride/Acetaminophen) Versus ULTRAM® (Tramadol Hydrochloride) Versus Placebo in Patients With Pain After Oral Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial comparing ULTRACET (tramadol hydrochloride/acetaminophen) vs ULTRAM (tramadol hydrochloride) and placebo for postoperative pain after oral surgery…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ULTRACET (tramadol hydrochloride/acetaminophen)
  • Ultram (tramadol)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Surgery, Oral, Pain, Postoperative | Phase 4 | Status: COMPLETED